Perceptive Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-3,000
Closed -$176K 146
2014
Q2
$176K Buy
+3,000
New +$189K 0.02% 93
2013
Q4
Sell
-255,810
Closed -$13.5M 136
2013
Q3
$13.5M Buy
+255,810
New +$17.2M 1.09% 20
2013
Q2
Hold
0
42

Perceptive Advisors's ARNA Position: Q1 2022 in Review

Perceptive Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 500,000 shares — an estimated $46.5M sold.

Perceptive Advisors first reported a position in ARNA in Q4 2017 and held it in 15 quarters. The position peaked at $80.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Perceptive Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Perceptive Advisors sold 500,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $46.5M.
  • Perceptive Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 15 quarters.
  • Perceptive Advisors's Arena Pharmaceuticals Inc position peaked at $80.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Perceptive Advisors's 13F filing for Q1 2022, filed 16 May 2022.